TrialPloS one2026

A multicenter, randomized, parallel-group confirmatory study protocol to evaluate the efficacy of Soft Protector CPC, a novel oral mucosal protectant, in preventing oral mucositis and alleviating pain in patients with breast cancer.

Kazuhiro Omori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.